Stimulation of human synovial fibroblast plasminogen activator production by mononuclear cell supernatants.

JA Hamilton, J Slywka - Journal of immunology (Baltimore, Md …, 1981 - journals.aai.org
Conditioned medium from concanavalin A-stimulated human peripheral blood mononuclear
cells (c-MCCM) stimulates the plasminogen activator (PA) production of nonrheumatoid …

[HTML][HTML] A titrated morphine analgesic regimen comparing substance users and non-users with AIDS-related pain

R Kaplan, J Slywka, S Slagle, K Ries - Journal of pain and symptom …, 2000 - Elsevier
To compare morphine dosage and effectiveness in AIDS patients with/without prior substance
use and pain, a prospective, open-label case series lasting 3–18 days was conducted in …

Human synovial fibroblast plasminogen activator. Modulation of enzyme activity by antiinflammatory steroids

…, A Bootes, PE Phillips, J Slywka - Arthritis & Rheumatism …, 1981 - Wiley Online Library
… Hamilton JA, Slywka J: Stimulation of human synovial fibroblast plasminogen activator
production by mononuclear cell supernatants. J Immunol 1263351-855, 1981 9. Werb Z: …

Changes in liver lysosome fragility, erythrocyte membrane stability, and local and systemic lysosomal enzyme levels in adjuvant-induced polyarthritis

LJ Ignarro, J Slywka - Biochemical Pharmacology, 1972 - Elsevier
Adjuvant-induced polyarthritis in rats is characterized by the development of liver lysosome
fragility, and elevated plasma and local hind paw activities of lysosomal acid hydrolases. …

Release of enzymes from a rat liver lysosome fraction: inhibition by catecholamines and cyclic 3', 5'-adenosine monophosphate, stimulation by cholinergic agents and …

LJ IGNARRO, N KRASSIKOFF, J SLYWKA - Journal of Pharmacology and …, 1973 - ASPET
Adrenergic agents and cyclic 3',5'-adenosine monophosphate inhibited, whereas cholinergic
agents and cyclic 3',5'-guanosine monophosphate accelerated, the release of enzymes …

Sustained-release morphine sulfate in the management of pain associated with acquired immune deficiency syndrome

…, R Maciewicz, K Ries, NS Slagle, J Slywka… - Journal of pain and …, 1996 - Elsevier
J-severe, and 4=overwhelming) was used to rat’! the patient’s PI four times each day:
overnight, … Only 7% required ongoing treatment of the side elect j 3t the end of the study. This …

Inhibition of lysosomal enzyme release by catecholamines: Possible mediation by cyclic 3′, 5′-adenosine monophosphate

LJ Ignarro, J Slywka, N Krassikoff - Life Sciences, 1971 - Elsevier
The catecholamines norepinephrine and epinephrine inhibit the release of enzymes from
lysosomes obtained from a rat liver mitochondrial preparation. Cyclic 3′, 5′-adenosine …

Inhibition of lysosomal enzyme release by adenosine 5′ triphosphate and N8, O2-dibutyryl cyclic 3′, 5′-adenosine monophosphate

LJ Ignarro, N Krassikoff, J Slywka - Life Sciences, 1972 - Elsevier
Adenosine 5′ triphosphate (ATP) and N 6 ,O 2 -dibutyryl cyclic 3′,5′-adenosine
monophosphate (dibutyryl cyclic AMP) inhibit the release of enzymes from lysosomes obtained from …

Analgesic efficacy and safety of two oral controlled-release morphine preparations in orthopedic postoperative pain.

SA Cooper, R Fitzmartin, J Slywka, BJ Buckley… - Advances in …, 1994 - europepmc.org
This single-dose, double-blind, randomized, parallel-group study compared the analgesic
efficacy and safety of MS Contin (MSC) and Oramorph SR (OSR), two controlled-release …

Autoradiographic assessment of the distal response to gingival injury

EA Tonna, SS Stahl, J Slywka - Journal of Periodontal …, 1977 - Wiley Online Library
Twelve young BNL mice received a “gingivectomy” excising the gingival papilla mesial to
the left maxillary first molar. Twelve additional young mice served as uninjured controls. One …